|
|
Editorials from Nucl Med Biol
| Validation of Radiotracers – Editorials from Nucl Med Biol |
- Eckelman WC, Mathis CA. Molecular targets. Nucl Med Biol. 2006 Jan;33(1):1.
- Eckelman WC, Mathis CA. Targeting proteins in vivo: in vitro guidelines. Nucl Med Biol. 2006 Feb;33(2):161-4.
- Eckelman WC, Kilbourn MR, Mathis CA. Discussion of targeting proteins in vivo: in vitro guidelines. Nucl Med Biol. 2006 May;33(4):449-51.
- Eckelman WC, Kilbourn MR, Mathis CA. Radiopharmaceutical space. Nucl Med Biol. 2006 Oct;33(7):829.
- Eckelman WC, Erba PA, Schwaiger M, Wagner HN Jr, Alberto R, Mazzi U. Postmeeting summary on the round table discussion at the Seventh International Symposium on Technetium in Chemistry and Nuclear Medicine held in Bressanone, Italy on Sept 6-9, 2006. Nucl Med Biol. 2007 Jan;34(1):1-4.
- Eckelman WC, Kilbourn MR, Joyal JL, Labiris R, Valliant JF. Justifying the number of animals for each experiment. Nucl Med Biol. 2007 Apr;34(3):229-32.
- Eckelman WC, Vera DR. After bench to bedside: the impact of disease progression, commercial opportunities and available instrumentation on clinical outcome. Nucl Med Biol. 2007 Oct;34(7):727-8.
- Eckelman WC. Further discussions on choosing the number of animals for an experiment. Nucl Med Biol. 2008 Jan;35(1):1-2.
- Eckelman WC, Bonardi M, Volkert WA. True radiotracers: are we approaching theoretical specific activity with Tc-99m and I-123? Nucl Med Biol. 2008 Jul;35(5):523-7.
- Eckelman WC, Kilbourn MR, Mathis CA. Specific to non-specific binding in radiopharmaceutical studies: It's not so simple as it seems! Nucl Med Biol 2009 Apr;36(3):235-7.
|
Related Items
|
|
